Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Postpartum Furosemide in Recovery of Patients With Severe Preeclampsia
Sponsor: Lady Reading Hospital, Pakistan
Summary
This randomized controlled trial will compare oral furosemide with placebo for improving blood pressure control in women with severe preeclampsia after delivery. Participants will receive either 20 mg of furosemide or a placebo tablet once daily for 5 days, in addition to standard postpartum treatment for high blood pressure. Blood pressure, symptoms, adverse events, and the need for additional antihypertensive medication will be monitored for 7 days after delivery. The study will assess whether adding furosemide helps achieve better postpartum blood pressure control compared with placebo.
Official title: Efficacy of Postpartum Furosemide in Patients With Severe Preeclampsia: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
434
Start Date
2026-10-01
Completion Date
2027-05-25
Last Updated
2026-10-06
Healthy Volunteers
No
Conditions
Interventions
Furosemide and Potassium
Furosemide 20 mg tablet administered orally once daily for 5 days after delivery as an add-on to standard postpartum antihypertensive treatment.
Placebo
Placebo tablet administered orally once daily for 5 days after delivery, in addition to standard postpartum antihypertensive treatment, including blood pressure monitoring and labetalol when required.
Locations (1)
Lady Reading Hospital
Peshawar, Khyber Pakhtunkhwa, Pakistan